Glaxo
forum
GLAXO Share Price Discussion
GlaxoSmithKline Pharmaceuticals Ltd.
Sector: Pharmaceuticals and health care
Sector: Pharmaceuticals and health care
GLAXO Share Price *
1,407.3 +42.75 (3.13%)
* (quote may be delayed)
GLAXO Discussion Forum
CASH INTRADAY CALL (11 SEPT 2019)
GLAXO BUY ABOVE 1333M SL - 1321, TGT - 1364 & 1402
Like
reply
Reply (1)
share
Share
Latest replies
FROM 1333 TO 1400 (67 POINTS) PROFIT (+5% UP)
Pharma companies cheer good monsoon as demand for anti-infective drugs rises
Anti-infective drugs grew at 15.3 percent YoY in August, compared to Indian pharmaceutical market growth of 9.4 percent.
Anti-infective drugs grew at 15.3 percent YoY in August, compared to Indian pharmaceutical market growth of 9.4 percent.
Moneycontrol
Like
reply
Reply
share
Share
Government scrambles to address shortage of rabies vaccine after GSK exit
Sources within the vaccine industry said that one of the main reasons for the current shortage was due to the exit of Chiron Behring Vaccines, a unit of GlaxoSmithKline (GSK).
Sources within the vaccine industry said that one of the main reasons for the current shortage was due to the exit of Chiron Behring Vaccines, a unit of GlaxoSmithKline (GSK).
Moneycontrol
Like
reply
Reply
share
Share
Focus on selective products, therapies starting to pay dividends: GSK Pharma
Vaidheesh hinted at new launches such as a vaccine (Bexsero) to protect infants against Meningitis B and a new drug to treat autoimmune disorders
Vaidheesh hinted at new launches such as a vaccine (Bexsero) to protect infants against Meningitis B and a new drug to treat autoimmune disorders
Moneycontrol
Like
reply
Reply
share
Share
Hold GlaxoSmithKline Consumer Healthcare; target of Rs 7972: Prabhudas Lilladher
Prabhudas Lilladher recommended hold rating on GlaxoSmithKline Consumer Healthcare with a target price of Rs 7972 in its research report dated August 05, 2019.
Prabhudas Lilladher recommended hold rating on GlaxoSmithKline Consumer Healthcare with a target price of Rs 7972 in its research report dated August 05, 2019.
moneycontrol.com
Like
reply
Reply
share
Share
GSK Pharma Q1 net profit up 35% at Rs 113.54 cr
Like
reply
Reply
share
Share
GSK to focus on 20 brands, 5 disease segments to drive India growth
Like
reply
Reply
share
Share
MNCs may delist if govt imposes 35% public shareholding norms; 14 stocks in focus
Like
reply
Reply
share
Share
Indian pharma market growth cools off to 7.9% in Q1 FY20
Like
reply
Reply
share
Share
Indian pharmaceutical market growth slows to 7% in May
Like
reply
Reply
share
Share
CCI approves GSK, Pfizer consumer healthcare JV formation
Like
reply
Reply
share
Share
It will grow huge in next 2 days
Like
reply
Reply
share
Share
Indian pharma market grows 9.4% in 2018 led by medicines for chronic diseases
Like
reply
Reply
share
Share
Fund managers' picks: Large, mid & smallcap stocks that MFs bought, sold in Dec
Like
reply
Reply
share
Share
India pharma market slows due to lower offtake of anti-infective, respiratory drugs
Like
reply
Reply
share
Share
Why GSK had to sell its Indian consumer health business
Like
reply
Reply
share
Share
- NewsBotSep 9 11:33 PMPharma companies cheer good monsoon as demand for anti-infective drugs risesMoneycontrolNewsBotSep 4 12:13 AMGovernment scrambles to address shortage of rabies vaccine after GSK exitMoneycontrolNewsBotAug 21 3:29 PMFocus on selective products, therapies starting to pay dividends: GSK PharmaMoneycontrolNewsBotAug 7 9:38 PMHold GlaxoSmithKline Consumer Healthcare; target of Rs 7972: Prabhudas Lilladhermoneycontrol.comNewsBotJul 22 10:38 PMGSK Pharma Q1 net profit up 35% at Rs 113.54 crNewsBotJul 16 2:38 AMGSK to focus on 20 brands, 5 disease segments to drive India growthNewsBotJul 10 7:53 PMMNCs may delist if govt imposes 35% public shareholding norms; 14 stocks in focusNewsBotJul 9 10:18 PMIndian pharma market growth cools off to 7.9% in Q1 FY20NewsBotJun 15 3:18 AMIndian pharmaceutical market growth slows to 7% in MayNewsBotMay 24 7:13 PMCCI approves GSK, Pfizer consumer healthcare JV formation
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.